It should be pointed out that although Egr1 expression is reduced in BCR-ABL expressing hematopoietic cells, loss of Egr1, similar to other critical tumor suppressors like Pten and and p53 [18, 25], still has a significant impact on the progression of BCR-ABL induced leukemia. This evidence concerns the gene ABL1 and leukemia.